Complete hematological and major molecular response through treatment with low‐dose Interferon alpha 2a in high‐risk polycythemia vera patient: a case report

Abstract Low‐dose interferon‐α 2a treatment may be considered as an alternative to cytoreductive therapy with hydroxyurea or regularly dosed interferon in high‐risk polycythemia vera patients.

Guardado en:
Detalles Bibliográficos
Autores principales: Christoph Driessen, Christoph Noppen, Georg Boonen, Juergen Drewe
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
R
Acceso en línea:https://doaj.org/article/5c0ee879362c4452a3469335c3c0f0a6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!